Lipocalin-2 levels increase in plasma of non-alcoholic fatty liver disease patients with metabolic syndrome

ConclusionThe plasma lipocalin levels increase in NAFLD with metabolic syndrome and it can be considered a good blood biomarker. The early detection in NAFLD cases may improve prognosis.

http://link.springer.com/10.1007/s13410-022-01058-3

Source: International Journal of Diabetes in Developing Countries - March 3, 2022 Category: Endocrinology Source Type: research